NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $12.14 -0.15 (-1.19%) Closing price 03:59 PM EasternExtended Trading$12.18 +0.03 (+0.26%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Avanos Medical Stock (NYSE:AVNS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Avanos Medical alerts:Sign Up Key Stats Today's Range$12.03▼$12.4150-Day Range$12.05▼$15.7252-Week Range$11.84▼$25.36Volume707,888 shsAverage Volume340,701 shsMarket Capitalization$558.66 millionP/E Ratio35.72Dividend YieldN/APrice TargetN/AConsensus RatingHold Company OverviewAvanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More… Avanos Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks43rd Percentile Overall ScoreAVNS MarketRank™: Avanos Medical scored higher than 43% of companies evaluated by MarketBeat, and ranked 383rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Avanos Medical.Read more about Avanos Medical's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth31.06% Earnings GrowthEarnings for Avanos Medical are expected to grow by 31.06% in the coming year, from $1.32 to $1.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is 35.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is 35.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.56.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.46. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Avanos Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.08% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently increased by 29.12%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.08% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently increased by 29.12%, indicating that investor sentiment is decreasing significantly. News and Social Media1.8 / 5News Sentiment0.24 News SentimentAvanos Medical has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Avanos Medical this week, compared to 3 articles on an average week. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $106,750.00 in company stock.Percentage Held by InsidersOnly 2.64% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Stock News HeadlinesAvanos Medical Q2 EPS Forecast Decreased by Zacks ResearchApril 30, 2025 | americanbankingnews.comAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial ResultsApril 28, 2025 | prnewswire.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 5, 2025 | Stansberry Research (Ad)Avanos Medical Shareholders Approve Key Proposals at Annual MeetingApril 27, 2025 | investing.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Catalyst Pharma (CPRX), Ascendis Pharma (ASND) and Avanos Medical (AVNS)April 22, 2025 | markets.businessinsider.comAvanos Names Pickett Interim CFO as Greiner DepartsApril 18, 2025 | marketwatch.comAvanos Medical: Cheap, But With CaveatsApril 17, 2025 | seekingalpha.comAvanos takes control over sales and distribution of MIC-KEY products in the UKApril 3, 2025 | markets.businessinsider.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $15.92 at the beginning of the year. Since then, AVNS shares have decreased by 23.7% and is now trading at $12.1440. View the best growth stocks for 2025 here. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings data on Wednesday, February, 26th. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.03. The firm had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a trailing twelve-month return on equity of 4.70% and a net margin of 2.30%. Read the conference call transcript. Who are Avanos Medical's major shareholders? Top institutional shareholders of Avanos Medical include Brown Advisory Inc. (4.20%), Tributary Capital Management LLC (1.60%), Bank of New York Mellon Corp (0.72%) and Principal Financial Group Inc. (0.53%). Insiders that own company stock include Michael Greiner, Kerr Holbrook and Julie Ann Shimer. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA). Company Calendar Last Earnings2/26/2025Today5/05/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees4,040Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($8.53) Trailing P/E Ratio36.04 Forward P/E Ratio9.28 P/E GrowthN/ANet Income$-61,800,000.00 Net Margins2.30% Pretax Margin3.83% Return on Equity4.70% Return on Assets3.46% Debt Debt-to-Equity Ratio0.12 Current Ratio2.22 Quick Ratio1.46 Sales & Book Value Annual Sales$687.80 million Price / Sales0.82 Cash Flow$1.60 per share Price / Cash Flow7.64 Book Value$26.63 per share Price / Book0.46Miscellaneous Outstanding Shares46,003,000Free Float44,146,000Market Cap$563.31 million OptionableOptionable Beta1.13 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (NYSE:AVNS) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredU.S. Stock Market Now on Verge of CollapseThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.